Health
5.2
Lilly criticizes Belgium's refusal to reimburse obesity drug Mounjaro
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateLe SoirLow-rated sourceBE
MarketsReportedLow
2.0
Eli Lilly hits record high ahead of Q3 earnings, Goldman sees beat
Eli Lilly shares reached an all-time high on Tuesday, driven by positive sentiment ahead of its quarterly results next week. Goldman Sachs expects the company to exceed its outlook, fueling investor optimism. The move reflects broader strength in healthcare equities, though the sustainability depends on actual earnings delivery.
Score Breakdown
Mosaic Score2.0
Model confidence0.5
Significance0.1
Source credibility0.3
Intelligence Tags
Entities
United Statescountry
Related signals
8 foundMarkets
5.2
UCB Raises 2026 Revenue Growth Forecast to 20%+ on Bimzelx, Cimzia Strength
Published 4 h ago1 sourceEvidence: Reported
SeverityModerateLe SoirLow-rated sourceBE · US
Markets
2.1
Orion raises 2026 outlook on faster royalty growth
Published 1 d ago1 sourceEvidence: Reported
Dagens IndustriLow-rated sourceFI
Markets
2.1
Orexo Q3 2026 Loss Widens on Restructuring, DOJ Settlement
Published 6 h ago1 sourceEvidence: Reported
Dagens IndustriLow-rated sourceSE · US
Markets
2.1
Hemnet Q3 Operating Income Falls 26%, Company Calls It 'Decisive Turning Point'
Published 5 h ago1 sourceEvidence: Reported
Dagens IndustriLow-rated sourceSE
Markets
2.1
Fastpartner Q3 Rental Income Dips, Stock Rises 1.2%
Published 17 min ago1 sourceEvidence: Reported
Dagens IndustriLow-rated sourceSE
Markets
8.6
Tesla beats Q3 expectations; historic merger under consideration
Published 15 h ago8 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyE24Low-rated sourceUS
Markets
8.0
SpaceX Earnings Beat and Tesla Deal Talks Fuel AI Rally
Published 23 h ago3 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyNew York TimesLow-rated sourceUS